In	in	In
2013	2013	2013
,	,	,
Gilead	gilead	Gilead
Sciences	scienc	Sciences
Inc	inc	Inc
.	.	.
filed	file	filed
an	an	an
application	applic	application
with	with	with
the	the	the
FDA	fda	FDA
for	for	for
a	a	a
new	new	new
drug	drug	drug
that	that	that
they	they	they
claimed	claim	claimed
could	could	could
cure	cure	cure
hepatitis	hepat	hepatitis
C	c	C
.	.	.
The	the	The
drug	drug	drug
was	was	wa
nothing	noth	nothing
short	short	short
of	of	of
a	a	a
miracle	miracl	miracle
.	.	.
The	the	The
new	new	new
wonder	wonder	wonder
drug	drug	drug
was	was	wa
named	name	named
Sovaldi	sovaldi	Sovaldi
.	.	.
Where	where	Where
previous	previous	previous
hep	hep	hep
C	c	C
treatments	treatment	treatment
had	had	had
a	a	a
minimal	minim	minimal
success	success	success
rate	rate	rate
and	and	and
involved	involv	involved
6	6	6
-12	-12	-12
months	month	month
of	of	of
grueling	gruel	grueling
treatment	treatment	treatment
that	that	that
involved	involv	involved
a	a	a
slew	slew	slew
of	of	of
harsh	harsh	harsh
side	side	side
effects	effect	effect
,	,	,
Sovaldi	sovaldi	Sovaldi
cured	cure	cured
people	peopl	people
at	at	at
a	a	a
94	94	94
rate	rate	rate
in	in	in
one	one	one
12	12	12
-week	-week	-week
treatment	treatment	treatment
.	.	.
It	it	It
was	was	wa
so	so	so
good	good	good
,	,	,
that	that	that
Gilead	gilead	Gilead
received	receiv	received
the	the	the
FDA	fda	FDA
s	s	s
Breakthrough	breakthrough	Breakthrough
Therapy	therapi	Therapy
Designation	design	Designation
,	,	,
which	which	which
is	is	is
given	given	given
to	to	to
drugs	drug	drug
that	that	that
show	show	show
a	a	a
tremendous	tremend	tremendous
advance	advanc	advance
over	over	over
existing	exist	existing
options	option	option
and	and	and
treatments	treatment	treatment
.	.	.
After	after	After
an	an	an
astonishingly	astonish	astonishingly
fast	fast	fast
review	review	review
process	process	process
and	and	and
approval	approv	approval
by	by	by
the	the	the
FDA	fda	FDA
,	,	,
Gilead	gilead	Gilead
filed	file	filed
a	a	a
patent	patent	patent
for	for	for
Harvoni	harvoni	Harvoni
which	which	which
is	is	is
Sovaldi	sovaldi	Sovaldi
combined	combin	combined
with	with	with
an	an	an
NS5A	ns5a	NS5A
inhibitor	inhibitor	inhibitor
.	.	.
Demand	demand	Demand
for	for	for
Harvoni	harvoni	Harvoni
skyrocketed	skyrocket	skyrocketed
globally	global	globally
because	becaus	because
currently	current	currently
there	there	there
are	are	are
approximately	approxim	approximately
130	130	130
million	million	million
to	to	to
150	150	150
million	million	million
people	peopl	people
living	live	living
with	with	with
hepatitis	hepat	hepatitis
C	c	C
around	around	around
the	the	the
world	world	world
.	.	.
To	to	To
call	call	call
this	this	this
a	a	a
medical	medic	medical
advance	advanc	advance
of	of	of
historic	histor	historic
proportions	proport	proportion
would	would	would
be	be	be
putting	put	putting
it	it	it
mildly	mild	mildly
.	.	.
The	the	The
unfortunate	unfortun	unfortunate
fact	fact	fact
is	is	is
that	that	that
the	the	the
very	veri	very
thing	thing	thing
that	that	that
makes	make	make
Harvoni	harvoni	Harvoni
so	so	so
wonderful	wonder	wonderful
is	is	is
what	what	what
makes	make	make
it	it	it
absolutely	absolut	absolutely
terrible	terribl	terrible
if	if	if
you	you	you
happen	happen	happen
to	to	to
live	live	live
in	in	in
America	america	America
.	.	.
In	in	In
the	the	the
U	u	U
.	.	.
S	s	S
.	.	.
,	,	,
a	a	a
12	12	12
-week	-week	-week
course	cours	course
of	of	of
Harvoni	harvoni	Harvoni
costs	cost	cost
84	84	84
,	,	,
000	000	000
94	94	94
,	,	,
000	000	000
.	.	.
It	it	It
works	work	work
out	out	out
to	to	to
approximately	approxim	approximately
1000	1000	1000
per	per	per
pill	pill	pill
.	.	.
If	if	If
you	you	you
lived	live	lived
in	in	in
India	india	India
,	,	,
the	the	the
cost	cost	cost
per	per	per
pill	pill	pill
is	is	is
4	4	4
.	.	.
I	i	I
get	get	get
it	it	it
.	.	.
The	the	The
cost	cost	cost
to	to	to
develop	develop	develop
a	a	a
drug	drug	drug
can	can	can
be	be	be
staggering	stagger	staggering
.	.	.
Research	research	Research
and	and	and
development	develop	development
work	work	work
,	,	,
plus	plus	plus
the	the	the
employees	employe	employee
who	who	who
perform	perform	perform
it	it	it
,	,	,
are	are	are
not	not	not
free	free	free
.	.	.
Then	then	Then
there	there	there
are	are	are
trials	trial	trial
and	and	and
further	further	further
tests	test	test
.	.	.
It	it	It
all	all	all
gets	get	get
expensive	expens	expensive
.	.	.
But	but	But
here	here	here
is	is	is
the	the	the
problem	problem	problem
;	;	;
Gilead	gilead	Gilead
didn	didn	didn
t	t	t
do	do	do
any	ani	any
of	of	of
these	these	these
steps	step	step
.	.	.
It	it	It
turns	turn	turn
out	out	out
,	,	,
Sovaldi	sovaldi	Sovaldi
was	was	wa
already	alreadi	already
invented	invent	invented
by	by	by
a	a	a
group	group	group
called	call	called
Doctors	doctor	Doctors
of	of	of
the	the	the
World	world	World
at	at	at
Cardiff	cardiff	Cardiff
University	univers	University
in	in	in
2007	2007	2007
.	.	.
DotW	dotw	DotW
is	is	is
claiming	claim	claiming
that	that	that
Gilead	gilead	Gilead
merely	mere	merely
copied	copi	copied
their	their	their
publicly	public	publicly
funded	fund	funded
research	research	research
,	,	,
rushed	rush	rushed
it	it	it
through	through	through
FDA	fda	FDA
approval	approv	approval
and	and	and
patenting	patent	patenting
,	,	,
and	and	and
then	then	then
immediately	immedi	immediately
jacked	jack	jacked
the	the	the
price	price	price
to	to	to
reap	reap	reap
an	an	an
absolutely	absolut	absolutely
insane	insan	insane
profit	profit	profit
.	.	.
It	it	It
worked	work	worked
.	.	.
In	in	In
2014	2014	2014
,	,	,
Gilead	gilead	Gilead
had	had	had
a	a	a
total	total	total
revenue	revenu	revenue
of	of	of
24	24	24
.	.	.
9	9	9
billion	billion	billion
compared	compar	compared
to	to	to
11	11	11
.	.	.
2	2	2
billion	billion	billion
in	in	in
2013	2013	2013
.	.	.
Comparing	compar	Comparing
this	this	this
to	to	to
India	india	India
,	,	,
you	you	you
start	start	start
to	to	to
see	see	see
the	the	the
disgusting	disgust	disgusting
truth	truth	truth
of	of	of
it	it	it
all	all	all
.	.	.
The	the	The
Indian	indian	Indian
government	govern	government
denied	deni	denied
Gilead	gilead	Gilead
a	a	a
patent	patent	patent
in	in	in
their	their	their
country	countri	country
,	,	,
on	on	on
the	the	the
grounds	ground	ground
that	that	that
they	they	they
couldn	couldn	couldn
t	t	t
prove	prove	prove
that	that	that
the	the	the
drug	drug	drug
was	was	wa
more	more	more
effective	effect	effective
at	at	at
treating	treat	treating
hep	hep	hep
C	c	C
than	than	than
what	what	what
was	was	wa
invented	invent	invented
at	at	at
Cardiff	cardiff	Cardiff
University	univers	University
in	in	in
2007	2007	2007
.	.	.
This	this	This
has	has	ha
forced	forc	forced
Gilead	gilead	Gilead
to	to	to
actually	actual	actually
compete	compet	compete
in	in	in
a	a	a
free	free	free
market	market	market
.	.	.
Due	due	Due
to	to	to
not	not	not
having	have	having
a	a	a
government	govern	government
-sanctioned	-sanction	-sanctioned
monopoly	monopoli	monopoly
in	in	in
India	india	India
,	,	,
Gilead	gilead	Gilead
was	was	wa
forced	forc	forced
to	to	to
sell	sell	sell
their	their	their
pill	pill	pill
at	at	at
4	4	4
.	.	.
This	this	This
results	result	result
in	in	in
a	a	a
total	total	total
cost	cost	cost
to	to	to
save	save	save
your	your	your
life	life	life
of	of	of
about	about	about
340	340	340
.	.	.
For	for	For
the	the	the
cost	cost	cost
of	of	of
the	the	the
same	same	same
treatment	treatment	treatment
with	with	with
the	the	the
same	same	same
pill	pill	pill
in	in	in
America	america	America
,	,	,
where	where	where
we	we	we
have	have	have
the	the	the
most	most	most
amazing	amaz	amazing
healthcare	healthcar	healthcare
system	system	system
in	in	in
the	the	the
world	world	world
,	,	,
you	you	you
could	could	could
literally	liter	literally
move	move	move
to	to	to
India	india	India
,	,	,
live	live	live
there	there	there
for	for	for
about	about	about
2	2	2
years	year	year
,	,	,
take	take	take
the	the	the
drug	drug	drug
for	for	for
a	a	a
few	few	few
weeks	week	week
during	dure	during
that	that	that
time	time	time
,	,	,
get	get	get
cured	cure	cured
,	,	,
then	then	then
move	move	move
back	back	back
and	and	and
still	still	still
come	come	come
out	out	out
saving	save	saving
money	money	money
.	.	.
How	how	How
freaking	freak	freaking
ridiculously	ridicul	ridiculously
insane	insan	insane
is	is	is
this	this	this
?	?	?
!	!	!
A	a	A
lawsuit	lawsuit	lawsuit
was	was	wa
filed	file	filed
by	by	by
Doctors	doctor	Doctors
of	of	of
the	the	the
World	world	World
against	against	against
Gilead	gilead	Gilead
as	as	a
well	well	well
,	,	,
on	on	on
the	the	the
basis	basi	basis
that	that	that
the	the	the
drug	drug	drug
molecule	molecul	molecule
was	was	wa
not	not	not
sufficiently	suffici	sufficiently
innovative	innov	innovative
to	to	to
warrant	warrant	warrant
a	a	a
patent	patent	patent
.	.	.
Seeing	see	Seeing
as	as	a
India	india	India
s	s	s
regulatory	regulatori	regulatory
agencies	agenc	agency
and	and	and
patent	patent	patent
office	offic	office
has	has	ha
already	alreadi	already
concurred	concur	concurred
with	with	with
the	the	the
opinion	opinion	opinion
in	in	in
this	this	this
lawsuit	lawsuit	lawsuit
,	,	,
things	thing	thing
do	do	do
not	not	not
look	look	look
to	to	to
be	be	be
going	go	going
well	well	well
for	for	for
Gilead	gilead	Gilead
in	in	in
the	the	the
future	futur	future
.	.	.
I	i	I
personally	person	personally
wouldn	wouldn	wouldn
t	t	t
be	be	be
buying	buy	buying
their	their	their
stock	stock	stock
.	.	.
This	this	This
brings	bring	brings
us	us	u
to	to	to
the	the	the
heart	heart	heart
of	of	of
the	the	the
problem	problem	problem
.	.	.
Gilead	gilead	Gilead
essentially	essenti	essentially
ripped	rip	ripped
off	off	off
publicly	public	publicly
funded	fund	funded
work	work	work
,	,	,
copied	copi	copied
a	a	a
drug	drug	drug
,	,	,
then	then	then
innovated	innov	innovated
by	by	by
mixing	mix	mixing
it	it	it
with	with	with
a	a	a
secondary	secondari	secondary
drug	drug	drug
to	to	to
call	call	call
it	it	it
unique	uniqu	unique
.	.	.
This	this	This
justified	justifi	justified
the	the	the
technicalities	technic	technicality
required	requir	required
for	for	for
a	a	a
patent	patent	patent
,	,	,
but	but	but
it	it	it
violated	violat	violated
the	the	the
spirit	spirit	spirit
for	for	for
which	which	which
patents	patent	patent
are	are	are
intended	intend	intended
.	.	.
If	if	If
the	the	the
FDA	fda	FDA
and	and	and
U	u	U
.	.	.
S	s	S
.	.	.
patent	patent	patent
office	offic	office
did	did	did
some	some	some
due	due	due
diligence	dilig	diligence
and	and	and
used	use	used
India	india	India
as	as	a
a	a	a
precedent	preced	precedent
,	,	,
denying	deni	denying
Gilead	gilead	Gilead
their	their	their
vulture	vultur	vulture
capitalism	capit	capitalism
cash	cash	cash
cow	cow	cow
,	,	,
this	this	this
would	would	would
not	not	not
be	be	be
an	an	an
issue	issu	issue
.	.	.
The	the	The
FDA	fda	FDA
has	has	ha
a	a	a
problem	problem	problem
with	with	with
revolving	revolv	revolving
door	door	door
crony	croni	crony
capitalism	capit	capitalism
.	.	.
One	one	One
example	exampl	example
is	is	is
FDA	fda	FDA
member	member	member
Milton	milton	Milton
Packer	packer	Packer
,	,	,
who	who	who
chairs	chair	chair
the	the	the
Cardiovascular	cardiovascular	Cardiovascular
and	and	and
Renal	renal	Renal
Drugs	drug	Drugs
Advisory	advisori	Advisory
Committee	committe	Committee
.	.	.
Packer	packer	Packer
reviews	review	review
applications	applic	application
for	for	for
drugs	drug	drug
submitted	submit	submitted
to	to	to
the	the	the
FDA	fda	FDA
for	for	for
regulatory	regulatori	regulatory
approval	approv	approval
.	.	.
He	he	He
is	is	is
also	also	also
financed	financ	financed
by	by	by
Novartis	novarti	Novartis
and	and	and
has	has	ha
spoken	spoken	spoken
on	on	on
their	their	their
behalf	behalf	behalf
to	to	to
the	the	the
advisory	advisori	advisory
board	board	board
he	he	he
himself	himself	himself
chairs	chair	chair
.	.	.
He	he	He
has	has	ha
also	also	also
gone	gone	gone
to	to	to
bat	bat	bat
in	in	in
his	his	his
own	own	own
committee	committe	committee
for	for	for
GlaxoSmithKline	glaxosmithklin	GlaxoSmithKline
in	in	in
2003	2003	2003
,	,	,
Spoke	spoke	Spoke
for	for	for
Sanofi	sanofi	Sanofi
in	in	in
2009	2009	2009
,	,	,
and	and	and
consulted	consult	consulted
for	for	for
Pfizer	pfizer	Pfizer
in	in	in
2010	2010	2010
.	.	.
Packer	packer	Packer
s	s	s
activities	activ	activity
,	,	,
while	while	while
part	part	part
of	of	of
a	a	a
government	govern	government
board	board	board
meant	meant	meant
to	to	to
impartially	imparti	impartially
regulate	regul	regulate
pharmaceuticals	pharmaceut	pharmaceutical
on	on	on
behalf	behalf	behalf
of	of	of
the	the	the
nation	nation	nation
,	,	,
scream	scream	scream
conflict	conflict	conflict
of	of	of
interest	interest	interest
.	.	.
And	and	And
he	he	he
is	is	is
only	onli	only
one	one	one
person	person	person
among	among	among
many	mani	many
who	who	who
participate	particip	participate
in	in	in
this	this	this
sort	sort	sort
of	of	of
nonsense	nonsens	nonsense
.	.	.
Government	govern	Government
involvement	involv	involvement
in	in	in
a	a	a
market	market	market
,	,	,
especially	especi	especially
one	one	one
like	like	like
pharmaceuticals	pharmaceut	pharmaceutical
,	,	,
is	is	is
desperately	desper	desperately
needed	need	needed
.	.	.
However	howev	However
,	,	,
when	when	when
that	that	that
government	govern	government
involvement	involv	involvement
ends	end	end
up	up	up
being	be	being
corrupted	corrupt	corrupted
to	to	to
where	where	where
it	it	it
serves	serv	serf
the	the	the
needs	need	need
of	of	of
corporations	corpor	corporation
over	over	over
people	peopl	people
,	,	,
it	it	it
becomes	becom	becomes
a	a	a
government	govern	government
-sanctioned	-sanction	-sanctioned
monopoly	monopoli	monopoly
that	that	that
is	is	is
enforcible	enforc	enforcible
by	by	by
law	law	law
.	.	.
Real	real	Real
progressive	progress	progressive
regulatory	regulatori	regulatory
and	and	and
patent	patent	patent
reform	reform	reform
is	is	is
so	so	so
desperately	desper	desperately
needed	need	needed
in	in	in
America	america	America
,	,	,
and	and	and
any	ani	any
presidential	presidenti	presidential
candidate	candid	candidate
who	who	who
is	is	is
serious	serious	serious
about	about	about
helping	help	helping
the	the	the
middle	middl	middle
class	class	class
should	should	should
make	make	make
it	it	it
a	a	a
primary	primari	primary
focus	focus	focus
of	of	of
their	their	their
campaign	campaign	campaign
.	.	.
Featured	featur	Featured
image	imag	image
via	via	via
drugs	drug	drug
.	.	.
com	com	com
